• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Lancet. H1N1 pneumonitis treated with intravenous zanamivir

Giuseppe

Emeritus
H1N1 pneumonitis treated with intravenous zanamivir (The Lancet, Extract, edited)

[Original Full Document (Subscription): LINK. EDITED.]

H1N1 pneumonitis treated with intravenous zanamivir

I Michael Kidd, Jim Down, Eleni Nastouli, Rob Shulman, Paul R Grant, David CJ Howell, Mervyn Singer


On July 8, 2009, a 22-year-old woman, neutropenic after chemotherapy for Hodgkin?s disease, was referred to ICU with 3 days? (d) increasing dyspnoea, bilateral chest infiltrates, and laboratory-confirmed pandemic H1N1 2009 influenza virus infection not responding to oseltamivir 75 mg twice daily and broad-spectrum antimicrobials (mero penem, teicoplanin, and caspofungin).

No other organisms were detected from blood or respiratory tract. Deterioration necessitated invasive ventilation from ICU d 3 (fi gure). She remained in single organ failure requiring high inspired oxygen, protective lung ventilation (tidal volumes ≤6?8 mL/kg), and neutral fluid balance. Hydro cortisone was given (d 3?6), then gradually reduced and discontinued (d 13). Neutropenia recovered by d 6, although lymphopenia remained (...). High level H1N1 RNA was detected in bronchoalveolar lavage (BAL) on d 10, despite 6 d oseltamivir given nasogastrically; in view of high volume gastric aspirates, this was replaced by nebulised zanamivir (d 6?13). Treatment escalation on d 13?16 delivered neither clinical nor virological response (figure).

(...)

-
-----
 

Attachments

Back
Top